97 related articles for article (PubMed ID: 28915432)
1. New uses for old complexes: The very first report on the trypanocidal activity of symmetric trinuclear ruthenium complexes.
Possato B; Carneiro ZA; de Albuquerque S; Nikolaou S
J Inorg Biochem; 2017 Nov; 176():156-158. PubMed ID: 28915432
[TBL] [Abstract][Full Text] [Related]
2. An extended π-system and enhanced electronic delocalization on symmetric [Ru
Possato B; Deflon VM; Naal Z; Formiga ALB; Nikolaou S
Dalton Trans; 2017 Jun; 46(24):7926-7938. PubMed ID: 28604871
[TBL] [Abstract][Full Text] [Related]
3. Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi.
Fandzloch M; Arriaga JMM; Sánchez-Moreno M; Wojtczak A; Jezierska J; Sitkowski J; Wiśniewska J; Salas JM; Łakomska I
J Inorg Biochem; 2017 Nov; 176():144-155. PubMed ID: 28910663
[TBL] [Abstract][Full Text] [Related]
4. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
[TBL] [Abstract][Full Text] [Related]
5. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
[TBL] [Abstract][Full Text] [Related]
6. Anticancer and antitrypanosomal activities of trinuclear ruthenium compounds with orthometalated phenazine ligands.
da Silva CFN; Chrispim PBH; Possato B; Portapilla GB; Rohrabaugh TN; Ramos LCB; Santana da Silva R; de Albuquerque S; Turro C; Nikolaou S
Dalton Trans; 2020 Nov; 49(45):16440-16452. PubMed ID: 32776028
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
[TBL] [Abstract][Full Text] [Related]
8. Anti-Leishmania activity of new ruthenium(II) complexes: Effect on parasite-host interaction.
Costa MS; Gonçalves YG; Nunes DCO; Napolitano DR; Maia PIS; Rodrigues RS; Rodrigues VM; Von Poelhsitz G; Yoneyama KAG
J Inorg Biochem; 2017 Oct; 175():225-231. PubMed ID: 28783554
[TBL] [Abstract][Full Text] [Related]
9. Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
Salas JM; Caballero AB; Esteban-Parra GM; Méndez-Arriaga JM
Curr Med Chem; 2017; 24(25):2796-2806. PubMed ID: 28521698
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
[TBL] [Abstract][Full Text] [Related]
11. Heterobimetallic nickel(II) and palladium(II) complexes derived from S-benzyl-N- (ferrocenyl)methylenedithiocarbazate: Trypanocidal activity and interaction with Trypanosoma cruzi Old Yellow Enzyme (TcOYE).
Carneiro ZA; Lima JC; Lopes CD; Gaspari APS; de Albuquerque S; Dinelli LR; Veloso-Silva LLW; Paganelli MO; Libardi SH; Oliveira CG; Deflon VM; Oliveira RJ; Borges JC; Maia PIS
Eur J Med Chem; 2019 Oct; 180():213-223. PubMed ID: 31306908
[TBL] [Abstract][Full Text] [Related]
12. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of some novel 1-indanone thiazolylhydrazone derivatives as anti-Trypanosoma cruzi agents.
Caputto ME; Ciccarelli A; Frank F; Moglioni AG; Moltrasio GY; Vega D; Lombardo E; Finkielsztein LM
Eur J Med Chem; 2012 Sep; 55():155-63. PubMed ID: 22840495
[TBL] [Abstract][Full Text] [Related]
15. Gibbilimbol analogues as antiparasitic agents--Synthesis and biological activity against Trypanosoma cruzi and Leishmania (L.) infantum.
Varela MT; Dias RZ; Martins LF; Ferreira DD; Tempone AG; Ueno AK; Lago JH; Fernandes JP
Bioorg Med Chem Lett; 2016 Feb; 26(4):1180-3. PubMed ID: 26821820
[TBL] [Abstract][Full Text] [Related]
16. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo trypanocidal activity of flavonoids from Delphinium staphisagria against Chagas disease.
Marín C; Ramírez-Macías I; López-Céspedes A; Olmo F; Villegas N; Díaz JG; Rosales MJ; Gutiérrez-Sánchez R; Sánchez-Moreno M
J Nat Prod; 2011 Apr; 74(4):744-50. PubMed ID: 21466157
[TBL] [Abstract][Full Text] [Related]
19. Pt
Gonçalves ACR; Carneiro ZA; Oliveira CG; Danuello A; Guerra W; Oliveira RJ; Ferreira FB; Veloso-Silva LLW; Batista FAH; Borges JC; de Albuquerque S; Deflon VM; Maia PIS
Eur J Med Chem; 2017 Dec; 141():615-631. PubMed ID: 29107428
[TBL] [Abstract][Full Text] [Related]
20. Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.
Olmo F; Marín C; Clares MP; Blasco S; Albelda MT; Soriano C; Gutiérrez-Sánchez R; Arrebola-Vargas F; García-España E; Sánchez-Moreno M
Eur J Med Chem; 2013; 70():189-98. PubMed ID: 24158012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
